National Cancer Institute (NCI) - Experimental Therapeutics
This opportunity focuses on advancing novel therapeutic approaches for cancer.
Opportunity Overview
This funding opportunity supports research into experimental therapeutics for cancer. The goal is to accelerate the development and testing of new treatments.
Eligibility and Scope
The research must focus on novel therapeutic agents and preclinical/early clinical development.
Eligible Applicants:
- Academic institutions
- Research consortia
- Biotechnology companies
Scope:
Research must demonstrate potential for significant clinical impact.
Funding Details
Funding Period: 3 Years
Maximum Award Amount: $5,000,000
Submission Deadline: October 15, 2024
Submission Guidelines
Proposals must include:
- A detailed scientific rationale (Max 10 pages).
- A comprehensive budget breakdown.
- A team capability statement.
Review Process: Peer review followed by a scientific advisory board review.
Contact Information
For inquiries, please contact the Program Officer at NCI Therapeutics Division.
Email: therapeutics.info@nci.gov